Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Intestinal Transplantation

Interventions

BIOLOGICAL

Cell Therapy

Infusion of containing 1x106/kg CD34+ cells from donor bone marrow selected using the CliniMACS® CD34 Reagent System.

Trial Locations (1)

RECRUITING

Columbia University Irving Medical Center/NYP, New York